---
title: "Arvee Laboratories (India) Ltd (ARVEE) — Share Price, Financials & Analysis"
symbol: "ARVEE"
company: "Arvee Laboratories (India) Ltd"
canonical: "https://tapetide.com/stocks/ARVEE"
isin: "INE006Z01016"
nse_symbol: "ARVEE"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 205.09
generated_at: "2026-09-13T19:44:33.735Z"
---

# Arvee Laboratories (India) Ltd (ARVEE)

Canonical page: https://tapetide.com/stocks/ARVEE

## Company

- **NSE Symbol:** ARVEE
- **ISIN:** INE006Z01016
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2021-03-22
- **CEO:** Mr. Shalin Sudhakarbhai Patel
- **Employees:** 70
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** arveelabs.com

## About

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

## Latest Price

- **Price:** ₹180.69
- **Change:** -14.56 (-7.46%)
- **Open:** ₹195
- **Day High:** ₹195
- **Day Low:** ₹176.5
- **Previous Close:** ₹195.25
- **Volume:** 7318
- **As Of:** 2026-09-11T10:20:35+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:42.076218Z.

- **Market Cap:** ₹205.09 Cr
- **Classification:** Microcap
- **P/E (reported):** 53.1
- **P/E (TTM):** 49.23
- **EPS (TTM):** ₹3.67
- **Book Value:** ₹30.66
- **Price to Book:** 6.37
- **Dividend Yield:** 0%
- **ROE:** 6.87%
- **ROCE:** 9.24%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹31.51 Cr
- **Net Income:** ₹2.05 Cr
- **EBITDA:** ₹3.19 Cr
- **52-Week High:** ₹290.78
- **52-Week Low:** ₹129.11
- **RSI (14):** 62.97

## Tapetide Score

- **Score:** 50 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 47.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 90.12 | 9% |
| growth | 58.13 | 9% |
| momentum | 63.56 | 12% |
| ownership | 50 | 24% |
| quality | 51.9 | 22% |
| valuation | 22.27 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company is expected to give good quarter

### Weaknesses

- Stock is trading at 5.89 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -7.83% over past five years.
- Tax rate seems low
- Company has a low return on equity of 5.88% over last 3 years.
- Debtor days have increased from 91.4 to 121 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -105.74% | -107.17% | -112.28% |
| ebitda margin growth | 107.69% | -9.08% | -14.12% | -34.02% |
| net income growth | 240% | -2.38% | -17% | -1% |
| revenue growth | 59.63% | -19.41% | -20% | -8% |
| roce | — | 38.95% | -57.92% | 14.31% |
| roe | — | 90.3% | 8.39% | -45% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 8.91 | 7.7 | 6.14 | 10.6 | 12.53 | 8.91 | 6.45 | 7.48 | 3.45 | 9.78 | 10.8 | 17.23 |
| Expenses | 8.22 | 7.17 | 5.35 | 9.06 | 11.03 | 8.57 | 6.23 | 7.14 | 3.33 | 8.15 | 9.7 | 14.74 |
| Operating Profit | 0.69 | 0.53 | 0.79 | 1.54 | 1.5 | 0.34 | 0.22 | 0.34 | 0.12 | 1.63 | 1.1 | 2.49 |
| OPM % | 7.74 | 6.88 | 12.87 | 14.53 | 11.97 | 3.82 | 3.41 | 4.55 | 3.48 | 16.67 | 10.19 | 14.45 |
| Other Income | 0.09 | 0.19 | 0.21 | 0.11 | 0.16 | 0.19 | 0.21 | 0.17 | 0.23 | 0.14 | 0.15 | 0.18 |
| Interest | 0.08 | 0.05 | 0.05 | 0.08 | 0.05 | 0.05 | 0.07 | 0.04 | 0.04 | 0.07 | 0.08 | 0.06 |
| Depreciation | 0.42 | 0.35 | 0.37 | 0.31 | 0.3 | 0.28 | 0.27 | 0.29 | 0.3 | 0.3 | 0.31 | 0.32 |
| Profit before tax | 0.28 | 0.32 | 0.58 | 1.26 | 1.31 | 0.2 | 0.09 | 0.18 | 0.01 | 1.4 | 0.86 | 2.29 |
| Tax % | 25 | 25 | 81.03 | 25.4 | 25.19 | 25 | 22.22 | 5.56 | 0 | -30.71 | 38.37 | 26.2 |
| Net Profit | 0.21 | 0.24 | 0.12 | 0.94 | 0.98 | 0.15 | 0.07 | 0.17 | 0.01 | 1.83 | 0.52 | 1.69 |
| EPS in Rs | 0.19 | 0.22 | 0.11 | 0.85 | 0.89 | 0.14 | 0.06 | 0.15 | 0.01 | 1.66 | 0.47 | 1.53 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 47.78 | 54.9 | 45.42 | 47.38 | 40.33 | 61.35 | 30.35 | 38.49 | 31.51 | 41.26 |
| Expenses | 40.61 | 48.73 | 39.4 | 41.31 | 34.65 | 54.06 | 27.41 | 34.88 | 28.33 | 35.92 |
| Operating Profit | 7.17 | 6.17 | 6.02 | 6.07 | 5.68 | 7.29 | 2.94 | 3.61 | 3.18 | 5.34 |
| OPM % | 15.01 | 11.24 | 13.25 | 12.81 | 14.08 | 11.88 | 9.69 | 9.38 | 10.09 | 12.94 |
| Other Income | 0.23 | 0.35 | 0.35 | 0.56 | 0.46 | 1.35 | 0.64 | 0.66 | 0.69 | 0.7 |
| Interest | 3.33 | 1.63 | 0.99 | 0.58 | 0.37 | 0.39 | 0.25 | 0.25 | 0.23 | 0.25 |
| Depreciation | 2.15 | 2.35 | 2.29 | 2.41 | 2.32 | 2.08 | 1.5 | 1.15 | 1.21 | 1.23 |
| Profit before tax | 1.92 | 2.54 | 3.09 | 3.64 | 3.45 | 6.17 | 1.83 | 2.87 | 2.43 | 4.56 |
| Tax % | 43.23 | 11.02 | 25.89 | 26.37 | 25.51 | 33.23 | 42.62 | 25.09 | -3.7 | — |
| Net Profit | 1.09 | 2.26 | 2.3 | 2.68 | 2.57 | 4.12 | 1.05 | 2.15 | 2.53 | 4.05 |
| EPS in Rs | 0.99 | 2.05 | 2.09 | 2.43 | 2.33 | 3.74 | 0.95 | 1.95 | 2.3 | 3.67 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.05 | 5.51 | 5.51 | 5.51 | 11.02 | 11.02 | 11.02 | 11.02 | 11.02 | 11.02 |
| Reserves | 0.15 | 8.69 | 10.95 | 13.25 | 10.42 | 12.92 | 17.04 | 18.09 | 20.24 | 22.77 |
| Borrowings | 24.99 | 16.15 | 12.87 | 3.87 | 8.88 | 3.13 | 1 | 1 | 1.03 | 1.11 |
| Other Liabilities | 6.49 | 13.77 | 7.81 | 11 | 10.73 | 11.61 | 9.63 | 8.45 | 5.29 | 7.99 |
| Total Liabilities | 35.68 | 44.12 | 37.14 | 33.63 | 41.05 | 38.68 | 38.69 | 38.56 | 37.58 | 42.89 |
| Fixed Assets | 16.88 | 14.88 | 12.65 | 13.18 | 13.81 | 13.84 | 12.68 | 12.67 | 15.27 | 16.72 |
| CWIP | 0 | 1.18 | 2.32 | 1.78 | 0.97 | 0.98 | 1.53 | 2.62 | 0.73 | 0.9 |
| Investments | 0 | 0 | 1.95 | 3.09 | 2.03 | 0 | 0 | 0 | 0 | 1.7 |
| Other Assets | 18.8 | 28.06 | 20.22 | 15.58 | 24.24 | 23.86 | 24.48 | 23.27 | 21.58 | 23.57 |
| Total Assets | 35.68 | 44.12 | 37.14 | 33.63 | 41.05 | 38.68 | 38.69 | 38.56 | 37.58 | 42.89 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4.03 | 6.02 | 9.46 | 10.31 | 1.71 | 0.68 | 2.93 | 3.66 | -0.21 | -0.12 |
| Cash from Investing Activity | -1.4 | -1.23 | -2.85 | -3.08 | -0.6 | 0.06 | -1.26 | -2.16 | -1.32 | 0.5 |
| Cash from Financing Activity | -2.92 | -3.78 | -4.92 | -9.9 | 4.52 | -6.06 | -2.42 | -0.19 | -0.12 | -0.16 |
| Net Cash Flow | -0.29 | 1 | 1.68 | -2.67 | 5.63 | -5.32 | -0.75 | 1.31 | -1.64 | 0.23 |
| Free Cash Flow | 2.54 | 4.68 | 7.96 | 8.02 | -0.53 | -1.68 | 1.47 | 1.07 | -2.06 | -2.95 |
| CFO/OP | 57 | 96 | 158 | 184 | 44 | 29 | 64 | 139 | 10 | 3 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 87.12 | 118.25 | 52.66 | 52.4 | 60.7 | 109.78 | 72.94 | 73.48 | 79.66 | 121.05 |
| Inventory Days | 104.53 | 99.61 | 42.9 | 80.96 | 91.96 | 93.24 | 42.29 | 159.02 | 80.31 | 228.81 |
| Days Payable | 98.14 | 150.03 | 55.84 | 125.63 | 118.08 | 160.12 | 73.3 | 164.49 | 57.72 | 159.35 |
| Cash Conversion Cycle | 93.5 | 67.84 | 39.72 | 7.72 | 34.59 | 42.9 | 41.94 | 68.01 | 102.25 | 190.51 |
| Working Capital Days | 30.84 | 30.79 | -6.52 | 10.29 | -10.63 | 49.96 | 70.44 | 95.97 | 103.55 | 168.43 |
| ROCE % | 15.19 | 17.64 | 13.67 | 14.9 | 14.92 | 12.89 | 23.34 | 6.83 | 9.58 | 7.53 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.33% | 26.18% | 26.16% | 26.33% | 26.34% | 26.35% | 26.33% | 26.31% | 26.19% | 26.25% | 26.21% | 26.16% |
| Others | 0.17% | 0.32% | 0.34% | 0.17% | 0.16% | 0.15% | 0.17% | 0.19% | 0.31% | 0.25% | 0.28% | 0.33% |
| No. of Shareholders | 905 | 1372 | 1298 | 1480 | 1416 | 1623 | 1576 | 1505 | 1505 | 1861 | 1638 | 1596 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 6 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 177.25 | Buy |
| EMA (10) | 181.46 | Sell |
| SMA (20) | 173.9 | Buy |
| EMA (20) | 175.71 | Buy |
| SMA (50) | 165.43 | Buy |
| EMA (50) | 169.16 | Buy |
| SMA (100) | 165.19 | Buy |
| EMA (100) | 166.44 | Buy |
| SMA (200) | 168.93 | Buy |
| EMA (200) | 165.61 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.92 | Neutral |
| MACD (12,26,9) | 6.33 | Buy |
| Stochastic (14,3,3) | 53.76 | Neutral |
| ADX (14) | 33.87 | Buy |
| Williams %R (14) | -70.33 | Neutral |
| ATR (14) | 13.61 | High Volatility |
| ROC (12) | 3.37 | Buy |
| Stoch RSI (14) | 23.1 | Neutral |
| UO (7,14,28) | 45.78 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Cessation](https://nsearchives.nseindia.com/corporate/ARVEE_09092026172859_ltr.pdf) |
| 2026-08-04 | [Corrigendum](https://nsearchives.nseindia.com/corporate/ARVEE_04082026141231_corrigendum.pdf) |
| 2026-06-27 | [Trading Window](https://nsearchives.nseindia.com/corporate/ARVEE_27062026194212_letter_for_Trading_Windows.pdf) |
| 2026-06-15 | [Disclosure under SEBI Takeover Regulations](https://nsearchives.nseindia.com/corporate/team_sandeshc_10062026130001_47.pdf) |
| 2026-04-15 | [Price movement](https://nsearchives.nseindia.com/corporate/ARVEE_15042026173021_price_clarification.pdf) |
| 2026-03-27 | [Trading Window](https://nsearchives.nseindia.com/corporate/ARVEE_27032026122727_letter_for_Trading_Windows.pdf) |
| 2026-03-06 | [Price movement](https://nsearchives.nseindia.com/corporate/sviswanathan_06032026135638_ARVEE_24122025114802_price_clarification.pdf) |
| 2026-02-09 | [Corrigendum](https://nsearchives.nseindia.com/corporate/ARVEE_09022026145806_bmr.pdf) |
| 2025-12-30 | [Trading Window](https://nsearchives.nseindia.com/corporate/ARVEE_30122025133205_TW.pdf) |
| 2025-12-24 | [Price movement](https://nsearchives.nseindia.com/corporate/ARVEE_24122025114802_price_clarification.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ARVEE_07082026175732_RES.pdf) |
| 2026-05-19 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ARVEE_19052026144332_outcome.pdf) |
| 2026-02-13 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ARVEE_13022026191347_fs.pdf) |
| 2026-02-13 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ARVEE_13022026191511_fs.pdf) |
| 2025-11-14 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ARVEE_14112025170055_res.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 3 Feb - Board meeting on 11 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for To Consider And Approve Unaudited Financial Results Along With Limited Review Report For The Quarter & Ended On 31St December, 2025 3 Feb - Board meeting on 11 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8900906-dd78-49d3-88cb-32e8eb9615cc.pdf) |
| 13 April 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … | [Price movement 13 April 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …](https://www.nseindia.com/get-quotes/equity?symbol=ARVEE) |
| 11 Feb - Approved Q3 and nine-month unaudited results; Q3 loss Rs24.27L; IBC filed for Rs8.665 crore receivable. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, 11Th February, 2026 11 Feb - Approved Q3 and nine-month unaudited results; Q3 loss Rs24.27L; IBC filed for Rs8.665 crore receivable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79d5d216-dd31-49f3-bb21-4a5c1408e40f.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43ade51e-617b-4326-8208-bb7e7fc3d37f.pdf) |
| — | [Unaudited Financials Results For The Quarter Ended 31 St December 2025 11 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/287cf97e-3ec9-4923-ac78-38d9975f1c1f.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Jan](https://www.bseindia.com/xml-data/corpfiling/AttachHis/51310ae3-bcfb-429b-8bf0-ce743c25cc62.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/AR_31227_ARVEE_2025_2026_A_7805899_03092026163458.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/AR_27952_ARVEE_2024_2025_A_5379945_30082025160513.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25547_ARVEE_2023_2024_03092024155922.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23940_ARVEE_2022_2023_13102023152945_10132023160000.zip) |
| from nse | [Annual Report 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20372_ARVEE_2021_2022_14072022174729_07142022180002.zip) |
| from nse | [Annual Report 2021 from nse](https://archives.nseindia.com/annual_reports/AR_18859_ARVEE_2020_2021_24082021154521_24082021160001.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40ce3d16-84e6-4486-aa6d-11315d006ea5.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2fb5016-b07d-4c52-a17d-7d52ee2c01ae.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b33950fa-8e14-4d7d-9025-8cd9b89a509e.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533203/76597533203.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:44:33.735Z.